Caxton Associates (New York)’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-30,767	Closed	-$642K	–	608
2024 Q2	$642K	Buy	30,767 +15,453	+101%	+$323K	0.02%	304
2024 Q1	$225K	Buy	+15,314	New	+$225K	0.01%	415